Actinium Pharmaceuticals ...

AMEX: ATNM · Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT

Actinium Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 81K 1.03M 1.14M
Cost of Revenue
811K 790K 699K 524K
Gross Profit
-811K 81K 1.03M 1.14M
Operating Income
-42.12M -51.92M -34.1M -24.96M
Interest Income
3.88M 3.1M 1.09M 190K
Pretax Income
-38.24M -48.82M -33.02M -24.77M
Net Income
-38.24M -48.82M -33.02M -24.77M
Selling & General & Admin
12.08M 13.33M 12M 8.08M
Research & Development
30.05M 38.67M 23.14M 18.03M
Other Expenses
-811K n/a n/a n/a
Operating Expenses
41.31M 52M 35.13M 26.11M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
42.12M 52M 35.13M 26.11M
Income Tax Expense
n/a n/a n/a -190K
Shares Outstanding (Basic)
30.07M 26.6M 24.14M 20.57M
Shares Outstanding (Diluted)
30.07M 26.6M 24.14M 20.57M
EPS (Basic)
-1.27 -1.83 -1.37 -1.2
EPS (Diluted)
-1.27 -1.83 -1.37 -1.2
EBITDA
-37.43M -51.13M -33.41M -24.44M
EBIT
-38.24M -51.92M -34.1M -24.96M
Depreciation & Amortization
811K 790K 699K 524K